These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15644572)

  • 1. Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients.
    Mitsuhashi N; Tanaka Y; Kubo S; Ogawa S; Hayashi C; Uchino H; Shimizu T; Watada H; Kawasumi M; Onuma T; Kawamori R
    Endocr J; 2004 Dec; 51(6):545-50. PubMed ID: 15644572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes.
    Shinoda-Tagawa T; Yamasaki Y; Yoshida S; Kajimoto Y; Tsujino T; Hakui N; Matsumoto M; Hori M
    Diabetologia; 2002 Feb; 45(2):188-94. PubMed ID: 11935149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.
    Ahn CM; Hong SJ; Park JH; Kim JS; Lim DS
    Heart Vessels; 2011 Sep; 26(5):502-10. PubMed ID: 21153029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without cardiovascular event.
    Huh JH; Seok H; Lee BW; Kang ES; Lee HC; Cha BS
    Endocrine; 2014 Sep; 47(1):138-45. PubMed ID: 24381128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial.
    Katakami N; Kim YS; Kawamori R; Yamasaki Y
    Circulation; 2010 Jun; 121(23):2584-91. PubMed ID: 20516379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus.
    Ahn CW; Lee HC; Park SW; Song YD; Huh KB; Oh SJ; Kim YS; Choi YK; Kim JM; Lee TH
    Diabetes Res Clin Pract; 2001 Apr; 52(1):45-53. PubMed ID: 11182215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.
    Bonora E; Tessari R; Micciolo R; Zenere M; Targher G; Padovani R; Falezza G; Muggeo M
    Diabetes Care; 1997 Apr; 20(4):627-31. PubMed ID: 9096992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
    Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
    Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease.
    Yamasaki Y; Kodama M; Nishizawa H; Sakamoto K; Matsuhisa M; Kajimoto Y; Kosugi K; Shimizu Y; Kawamori R; Hori M
    Diabetes Care; 2000 Sep; 23(9):1310-5. PubMed ID: 10977024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids.
    Taniguchi A; Nakai Y; Fukushima M; Teramura S; Hayashi R; Hama K; Marumoto K; Watanabe T; Yoshioka I; Sakaguchi K; Kishimoto H; Matsushita K; Okumura T; Tokuyama K; Nagasaka S; Sakai M
    Metabolism; 2002 May; 51(5):539-43. PubMed ID: 11979382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Westernization of lifestyle markedly increases carotid intima-media wall thickness (IMT) in Japanese people.
    Watanabe H; Yamane K; Fujikawa R; Okubo M; Egusa G; Kohno N
    Atherosclerosis; 2003 Jan; 166(1):67-72. PubMed ID: 12482552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients.
    Heo SH; Lee JS; Kim BJ; Hwang KJ; Kim JH; Chang DI
    J Neurol; 2013 Jan; 260(1):122-30. PubMed ID: 22820682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.
    Beishuizen ED; van de Ree MA; Jukema JW; Tamsma JT; van der Vijver JC; Meinders AE; Putter H; Huisman MV
    Diabetes Care; 2004 Dec; 27(12):2887-92. PubMed ID: 15562202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cilostazol on carotid plaque volume measured by three-dimensional ultrasonography in patients with type 2 diabetes: The FANCY study.
    Lee DH; Chun EJ; Moon JH; Yun HM; Lim S
    Diabetes Obes Metab; 2020 Dec; 22(12):2257-2266. PubMed ID: 32700396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
    Taniwaki H; Kawagishi T; Emoto M; Shoji T; Kanda H; Maekawa K; Nishizawa Y; Morii H
    Diabetes Care; 1999 Nov; 22(11):1851-7. PubMed ID: 10546019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes.
    Moussavi N; Renier G; Roussin A; Mamputu JC; Buithieu J; Serri O
    Diabetes Obes Metab; 2004 Jan; 6(1):69-77. PubMed ID: 14686966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.
    Matsumoto K; Sera Y; Abe Y; Tominaga T; Yeki Y; Miyake S
    Diabetes Res Clin Pract; 2004 Jun; 64(3):225-8. PubMed ID: 15126012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus.
    Shah AS; Dolan LM; Kimball TR; Gao Z; Khoury PR; Daniels SR; Urbina EM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3740-5. PubMed ID: 19723759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study.
    Baguet JP; Asmar R; Valensi P; Nisse-Durgeat S; Mallion JM
    Vasc Health Risk Manag; 2009; 5(1):175-83. PubMed ID: 19436670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.